Specifically, activation of mGluR5 has been shown to protect against neuronal loss in forebrain ischemia [32] and white matter damage in a rodent model of periventricular leukomalacia (PVL), the main cause of cerebral palsy and death in premature babies [27]. This evidence concerns the gene GRM5 and cerebral palsy.